This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01552/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB01552/identifier/wikipedia/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB01552/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01552/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB01552/identifier/drugbank/

Statements

Subject Item
n2:DB01552
rdf:type
n3:Drug
n3:description
Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. The stereoisomer alphameprodine is similarly classified, and was more widely used. Betameprodine is a structural analogue of meperidine. It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation -- as well as itching, nausea, and respiratory depression.
n3:group
experimental illicit
owl:sameAs
n6:DB01552 n11:DB01552
dcterms:title
Betameprodine
adms:identifier
n8:61118 n9:46505637 n10:55066 n12:Betameprodine n13:DB01552
n3:synonym
4-piperidinol, 3-ethyl-1-methyl-4-phenyl-, propionate ester beta-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine (3-ethyl-1-methyl-4-phenyl-piperidin-4-yl) propanoate Betameprodinum Meprodine 468-50-8 Nu 1732 Nu-1932 beta-1-Methyl-3-ethyl-4-phenyl-4-propionoxy-piperidin AC1L1UK6 Betameprodina (3-ethyl-1-methyl-4-phenylpiperidin-4-yl) propanoate propionic acid (3-ethyl-1-methyl-4-phenyl-4-piperidyl) ester 207-407-4
n3:IUPAC-Name
n4:271B54CA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B54D0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B54CF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B54CC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B54CD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B54CE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B54C8-363D-11E5-9242-09173F13E4C5 n4:271B54DF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B54C6-363D-11E5-9242-09173F13E4C5 n4:271B54C9-363D-11E5-9242-09173F13E4C5 n4:271B54E1-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B54C7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B54D6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B54D7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B54D1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B54D2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B54D4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B54D3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B54D5-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
468-50-8
n3:Bioavailability
n4:271B54DB-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B54E0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B54DD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B54DE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B54DA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B54D9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B54DC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B54CB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B54D8-363D-11E5-9242-09173F13E4C5